Whipplewood Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Whipplewood Advisors's VRTX Position: Q2 2026 in Review
Whipplewood Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 98% in Q2 2026, selling an estimated $94K and leaving 5 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #391.
Whipplewood Advisors first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $266K in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Whipplewood Advisors held 5 shares of Vertex Pharmaceuticals worth $2.48K as of Q2 2026.
- Whipplewood Advisors sold 212 Vertex Pharmaceuticals shares in Q2 2026, an estimated $94K.
- Vertex Pharmaceuticals made up ﹤0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #391 holding.
- Whipplewood Advisors first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
- Whipplewood Advisors's Vertex Pharmaceuticals position peaked at $266K in Q1 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.